State Street Corp Phathom Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 922,788 shares of PHAT stock, worth $7.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

922,788

Previous 785,249 17.52%

Holding current value

$7.51 Million

Previous $8.09 Million 106.28%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.25 - $19.5 $1.41 Million - $2.68 Million	137,539 Added 17.52%	922,788 $16.7 Million
Q2 2024 Aug 14, 2024	BUY	$8.97 - $12.05 $610,390 - $819,978	68,048 Added 9.49%	785,249 $8.09 Million
Q1 2024 May 15, 2024	BUY	$6.21 - $11.05 $182,350 - $324,472	29,364 Added 4.27%	717,201 $7.62 Million
Q4 2023 Feb 14, 2024	BUY	$6.99 - $10.71 $141,484 - $216,781	20,241 Added 3.03%	687,837 $6.28 Million
Q3 2023 Nov 14, 2023	BUY	$10.26 - $15.7 $1.41 Million - $2.16 Million	137,753 Added 26.0%	667,596 $6.92 Million
Q2 2023 Aug 14, 2023	BUY	$7.28 - $14.32 $481,208 - $946,552	66,100 Added 14.25%	529,843 $7.59 Million
Q1 2023 May 15, 2023	BUY	$6.19 - $12.36 $76,718 - $153,189	12,394 Added 2.75%	463,743 $3.31 Million
Q4 2022 Feb 14, 2023	BUY	$9.18 - $11.53 $53,739 - $67,496	5,854 Added 1.31%	451,349 $5.06 Million
Q3 2022 Nov 15, 2022	BUY	$6.46 - $12.11 $236,519 - $443,383	36,613 Added 8.95%	445,495 $4.94 Million
Q2 2022 Aug 15, 2022	BUY	$6.2 - $15.5 $271,795 - $679,489	43,838 Added 12.01%	408,882 $3.45 Million
Q1 2022 May 16, 2022	BUY	$11.55 - $20.06 $266,851 - $463,466	23,104 Added 6.76%	365,044 $4.97 Million
Q4 2021 Feb 14, 2022	SELL	$17.83 - $33.15 $228,651 - $425,115	-12,824 Reduced 3.61%	341,940 $6.73 Million
Q3 2021 Nov 15, 2021	BUY	$30.69 - $36.83 $443,808 - $532,598	14,461 Added 4.25%	354,764 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$32.66 - $39.87 $4.02 Million - $4.91 Million	123,105 Added 56.68%	340,303 $11.5 Million
Q1 2021 May 17, 2021	BUY	$33.86 - $48.68 $275,891 - $396,644	8,148 Added 3.9%	217,198 $8.16 Million
Q4 2020 Feb 16, 2021	SELL	$33.22 - $50.26 $174,637 - $264,216	-5,257 Reduced 2.45%	209,050 $6.95 Million
Q3 2020 Nov 10, 2020	BUY	$29.24 - $40.19 $43,860 - $60,285	1,500 Added 0.7%	214,307 $7.86 Million
Q2 2020 Aug 14, 2020	BUY	$25.06 - $54.6 $639,004 - $1.39 Million	25,499 Added 13.61%	212,807 $7 Million
Q1 2020 May 11, 2020	BUY	$24.65 - $42.83 $4.62 Million - $8.02 Million	187,308 New	187,308 $4.84 Million

Others Institutions Holding PHAT

# of Institutions

144

Shares Held

73.6M

Call Options Held

42.3K

Put Options Held

45.7K

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $319M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Phathom Pharmaceuticals, Inc. Transaction History